Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Placebo published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 142
» View latimes.com items only
    May 30, 2012 |Story| Los Angeles Times

  1. Widely used antioxidant supplement curtails some autism symptoms

    A widely used antioxidant supplement can reduce some of the symptoms of autism in children, a pilot study has found. The supplement -- N-acetylcysteine, or NAC -- lowered irritability in the children and reduced repetitive behaviors, researchers from the Stanford University School of Medicine reported in the journal Biological Psychiatry. The team cautioned, however, that only 31 children were enrolled and that larger studies are needed to confirm the potential benefit.
    A widely used antioxidant supplement can reduce some of the symptoms of autism in children, a pilot study has found. The supplement -- N-acetylcysteine, or NAC -- lowered irritability in the children and reduced repetitive behaviors, researchers from...

    Tags: Autism, Behavioral Conditions, Diabetes, Science and Technology, Stanford University

    2. May 25, 2012 |Story| Los Angeles Times

  2. Magnesium infusions provide no benefit after bleeding stroke

    The common practice of infusing magnesium sulfate into patients who have suffered a hemorrhagic (bleeding) stroke provides no discernible benefit, Dutch researchers reported Friday. The study could lead to a change in treatment for victims of such strokes, which account for about 13% of the estimated 795,000 strokes that afflict Americans each year -- and about 30% of the 133,000 stroke deaths. The rest of the strokes are caused by blood clots that impede circulation in the brain. Many survivors of hemorrhagic strokes, which occur when a blood vessel in the brain leaks blood into the organ, causing acute pressure, are left permanently impaired.
    The common practice of infusing magnesium sulfate into patients who have suffered a hemorrhagic (bleeding) stroke provides no discernible benefit, Dutch researchers reported Friday. The study could lead to a change in treatment for victims of such...

    Tags: Netherlands, Trials, Stroke, Physical Conditions, Health

    3. May 14, 2012 |Story| Los Angeles Times

  3. Smoking pot for multiple sclerosis? Study finds it helps

    Smoking marijuana to relieve the symptoms of multiple sclerosis is a practice with a fair number of adherents, though it has not been subject to rigorous testing. A new study finds that puffing weed does have a rapid and measurable effect on MS patients' muscle spasticity and on their perception of pain. But subjects who smoked pot were not able to walk any faster and -- surprise! -- they felt higher than members of the control group who smoked marijuana stripped of THC.
    Smoking marijuana to relieve the symptoms of multiple sclerosis is a practice with a fair number of adherents, though it has not been subject to rigorous testing. A new study finds that puffing weed does have a rapid and measurable effect on MS patients'...

    Tags: Lifestyle and Leisure, Drugs and Medicines, Recreational Substance Use, Multiple Sclerosis, Substance Abuse

    4. May 14, 2012 |Story| Los Angeles Times

  4. Could patients with COPD breathe easier with acupuncture?

    A new study offers some promising evidence that acupuncture may improve quality of life for patients with chronic obstructive pulmonary disease.
    A new study offers some promising evidence that acupuncture may improve quality of life for patients with chronic obstructive pulmonary disease. Researchers in Japan recruited 62 patients with COPD, a progressive disease that makes it hard for patients...

    Tags: Research, COPD, Blood, Japan, Human Body

    5. May 9, 2012 |Story| Los Angeles Times

  5. Drug delays progression in myeloma, but is it worth the cost?

    Lenalidomide, sold under the tradename Revlimid, significantly improves progression-free survival in patients with myeloma, according to three clinical trials published Wednesday. All three trials were so successful that the results were unblinded early and, in two of the three trials, patients receiving the placebo were switched to the active drug. But researchers also found that the drug doubled the risk of a second, independent cancer occurring, and it is not yet clear whether the drug produces an increase in overall survival. Moreover, the drug is quite expensive, more than $163,000 for a year of treatment, and there was no data indicating whether quality of life improved enough to justify the cost.
    Lenalidomide, sold under the tradename Revlimid, significantly improves progression-free survival in patients with myeloma, according to three clinical trials published Wednesday. All three trials were so successful that the results were unblinded early...

    Tags: Trials, Thalidomide (drug), Prednisone (drug), Blood Cells, Human Body

    6. Apr 24, 2012 |Story| Los Angeles Times

  6. Experimental drug helps the brain recover from stroke -- in mice

    Scientists have developed a &ldquo;proof of concept&rdquo; drug for stroke patients that helped afflicted mice recover the ability to walk normally. In laboratory experiments, the researchers also found biological evidence that the drug helped grow new neurons in the brain, according to <a href=&quot;http://stroke.ahajournals.org/content/early/2012/04/19/STROKEAHA.111.641878.abstract">a study published online Tuesday</a> by the journal Stroke.
    Scientists have developed a “proof of concept” drug for stroke patients that helped afflicted mice recover the ability to walk normally. In laboratory experiments, the researchers also found biological evidence that the drug helped grow new...

    Tags: Research, Stroke, Behavioral Conditions, Human Body, Science and Technology

    7. Apr 25, 2012 |Story| Los Angeles Times

  7. Gabapentin may ease symptoms of marijuana withdrawal

    Need help getting the marijuana monkey off your back? The widely prescribed anticonvulsant drug gabapentin might be just the ticket, if preliminary clinical trials at the Scripps Research Institute are confirmed. A 12-week trial in 50 marijuana users who wanted to quit showed that gabapentin (sold under a variety of brand names, including Neurontin) reduced withdrawal symptoms and that those who took the drug were more likely to stop smoking maryjane altogether.
    Need help getting the marijuana monkey off your back? The widely prescribed anticonvulsant drug gabapentin might be just the ticket, if preliminary clinical trials at the Scripps Research Institute are confirmed. A 12-week trial in 50 marijuana users...

    Tags: National Institutes of Health, Trials, Neurontin (drug), Behavioral Conditions, Quitting Smoking

    8. Mar 7, 2012 |Story| Los Angeles Times

  8. Estrogen taken alone is linked to lower breast cancer risk

    Many women who used estrogen alone as hormone replacement therapy after menopause had a lower risk of developing breast cancer up to five years after they stopped taking it, a study has found.
    Many women who used estrogen alone as hormone replacement therapy after menopause had a lower risk of developing breast cancer up to five years after they stopped taking it, a study has found. The research, published Tuesday, adds another twist to the...

    Tags: Menopause, Women's Health, Research, Symptoms, Science and Technology

    9. Mar 19, 2012 |Story| Los Angeles Times

  9. More data needed on experimental drug for diabetes: study

    Diabetes affects more than 25 million Americans. New medications and strategies to treat the disease are greatly needed. But the jury is still out on the experimental medication dapagliflozin.
    Diabetes affects more than 25 million Americans. New medications and strategies to treat the disease are greatly needed. But the jury is still out on the experimental medication dapagliflozin. The medication looks to have significant benefits and risks,...

    Tags: Human Body, Diabetes, Insulin, Cancer, AstraZeneca Plc

    10. Mar 6, 2012 |Story| Los Angeles Times

  10. Hormone replacement therapy questions continue

    Perhaps if there were other really effective medications to treat menopausal symptoms people wouldn't care so much about the safety of hormone replacement therapy.
    Perhaps if there were other really effective medications to treat menopausal symptoms people wouldn't care so much about the safety of hormone replacement therapy. But there aren't medications that work as well as estrogen alone (for women who have...

    Tags: Menopause, Human Body, Colon Cancer, Broken Hip, Breast Cancer

    11. Apr 9, 2012 |Story| Los Angeles Times

  11. Fish oil: Is it any good for us?

    Omega-3 fatty acids don&rsquo;t help people with preexisting heart disease avoid future cardiovascular trouble, a new study has found.&nbsp; What does this mean for fish oils and our health? &nbsp;
    Omega-3 fatty acids don’t help people with preexisting heart disease avoid future cardiovascular trouble, a new study has found.  What does this mean for fish oils and our health?   That’s not clear. Here’s what the study, reported...

    Tags: Dietary Supplements, Science and Technology, Heart Disease, Statins (drugs), Internal Medicine

    12. Mar 24, 2012 |Story| Los Angeles Times

  12. Raise a glass of wine to resveratrol

    Drinkers the world over have been thrilled by the notion that resveratrol, a chemical found in red wine, might be some kind of anti-aging powerhouse.
    Drinkers the world over have been thrilled by the notion that resveratrol, a chemical found in red wine, might be some kind of anti-aging powerhouse. The supposed wonder substance can make perilously chubby lab rats live as long as their slim...

    Tags: Diabetes, Albert Einstein, Wines, University of Pennsylvania, Medical Research

 1  2 3 4 5 6 7 8 9 10 11-12 • Next >
Advertisement
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Placebo Photos
A recent study has shown that men who take 400 internat...
(October 11, 2011)
&nbsp;